News on Leukemia_Lymphocytic_Chronic from BioPortfolio.com http://www.BioPortfolio.com Consolidated Leukemia_Lymphocytic_Chronic news from BioPortfolio.com Wed, 10 Feb 2010 00:51:36 GMT en TopAbstracts in Hypertension 02/03/2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010115&HITNO=0&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010115&THISHREF=http://c.moreover.com/click/here.pl%3fz2522250178%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010115&HITNO=0&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010115&THISHREF=http://c.moreover.com/click/here.pl%3fz2522250178%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-uphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999081&HITNO=1&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999081&THISHREF=http://c.moreover.com/click/here.pl%3fz2517316006%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999081&HITNO=1&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999081&THISHREF=http://c.moreover.com/click/here.pl%3fz2517316006%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMovement Disorders: Leading Lymphoma Expert Joins Perceptive Informatics Team of Medical Imaging Scientific Advisorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994158&HITNO=2&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994158&THISHREF=http://c.moreover.com/click/here.pl%3fz2514897324%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994158&HITNO=2&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994158&THISHREF=http://c.moreover.com/click/here.pl%3fz2514897324%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Expert Joins Medical Imaging Scientific Advisor Teamhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984490&HITNO=3&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984490&THISHREF=http://c.moreover.com/click/here.pl%3fz2508189575%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984490&HITNO=3&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984490&THISHREF=http://c.moreover.com/click/here.pl%3fz2508189575%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicexchange.com: New Drugs For Kidney Cancer And Chronic Lymphocytic Leukemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981755&HITNO=4&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981755&THISHREF=http://c.moreover.com/click/here.pl%3fz2507184737%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981755&HITNO=4&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981755&THISHREF=http://c.moreover.com/click/here.pl%3fz2507184737%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Lymphocytic Choriomeningitis Virus Meningitis, New York, NY, USA, 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971518&HITNO=5&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971518&THISHREF=http://c.moreover.com/click/here.pl%3fz2501907867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971518&HITNO=5&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971518&THISHREF=http://c.moreover.com/click/here.pl%3fz2501907867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCenter for Disease Control and Prevention: New Tools and Systems Can Help Primary Care Clinicians Manage Obesityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959975&HITNO=6&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959975&THISHREF=http://c.moreover.com/click/here.pl%3fz2495958447%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959975&HITNO=6&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959975&THISHREF=http://c.moreover.com/click/here.pl%3fz2495958447%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3947925&HITNO=7&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3947925&THISHREF=http://c.moreover.com/click/here.pl%3fz2488374719%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3947925&HITNO=7&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3947925&THISHREF=http://c.moreover.com/click/here.pl%3fz2488374719%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948230&HITNO=8&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948230&THISHREF=http://c.moreover.com/click/here.pl%3fz2488467123%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948230&HITNO=8&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948230&THISHREF=http://c.moreover.com/click/here.pl%3fz2488467123%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948049&HITNO=9&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948049&THISHREF=http://c.moreover.com/click/here.pl%3fz2488414433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948049&HITNO=9&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948049&THISHREF=http://c.moreover.com/click/here.pl%3fz2488414433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948047&HITNO=10&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948047&THISHREF=http://c.moreover.com/click/here.pl%3fz2488414339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948047&HITNO=10&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948047&THISHREF=http://c.moreover.com/click/here.pl%3fz2488414339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948045&HITNO=11&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948045&THISHREF=http://c.moreover.com/click/here.pl%3fz2488413899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948045&HITNO=11&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948045&THISHREF=http://c.moreover.com/click/here.pl%3fz2488413899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948044&HITNO=12&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948044&THISHREF=http://c.moreover.com/click/here.pl%3fz2488413898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948044&HITNO=12&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948044&THISHREF=http://c.moreover.com/click/here.pl%3fz2488413898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948273&HITNO=13&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948273&THISHREF=http://c.moreover.com/click/here.pl%3fz2488492392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948273&HITNO=13&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948273&THISHREF=http://c.moreover.com/click/here.pl%3fz2488492392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDMN Newswire: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948167&HITNO=14&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948167&THISHREF=http://c.moreover.com/click/here.pl%3fz2488435152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948167&HITNO=14&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Lymphocytic_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948167&THISHREF=http://c.moreover.com/click/here.pl%3fz2488435152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: